Vidipha Central Pharmaceutical JSC (HOSE:VDP)

Vietnam · Delayed Price · Currency is VND

32,450

+2,100 (6.92%)

At close: Oct 13, 2026

Market Cap	716.61B -36.4%
Revenue (ttm)	979.05B +3.8%
Net Income	62.51B -11.9%
EPS	2,830.53 -11.9%
Shares Out	22.08M
PE Ratio	11.46
Forward PE	n/a
Dividend	2,500.00 (7.70%)
Ex-Dividend Date	n/a

Volume	602
Open	32,450
Previous Close	30,350
Day's Range	32,450 - 32,450
52-Week Range	24,000 - 60,500
Beta	-0.20
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 21, 2026

About HOSE:VDP

Vidipha Central Pharmaceutical Joint Stock Company produces and sells pharmaceutical products in Vietnam. It offers analgesics, antipyretics, gastrointestinal agents, antidiabetic agents, antibiotics, antivirals, antifungals, antihistamines, anti-allergic agents, respiratory agents, cardiovascular, neurological, antihypertensive agents, diuretics, vitamins, minerals, antiseptics, and others. The company also engages in the hotel and real estate businesses; and provision of drug storage and testing, and technology transfer consulting services. I... [Read more]

Industry Pharmaceutical Preparations

Founded 2003

Employees 469

Stock Exchange Ho Chi Minh Stock Exchange

Ticker Symbol VDP

Full Company Profile

Financial Performance

In 2025, HOSE:VDP's revenue was 985.64 billion, an increase of 5.47% compared to the previous year's 934.49 billion. Earnings were 63.81 billion, a decrease of -11.16%.

Financial Statements